BUZZ-Aralez Pharmaceuticals Inc: Hits over 2-1/2-year low

Tue Mar 15, 2016 12:02pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Drug developer's U.S.-listed shares fall 18 pct to $4.76, lowest since May 2013

** Reports Q4 revenue of $6 mln vs $9.9 mln year earlier primarily due to increased costs associated with upcoming launch of its new drug Yosprala

** Net loss was 40 cents per share, compared with a profit of 21 cents per share year earlier

** Up to Monday's close, stock had fallen 15 pct this year